People who drink a lot of diet soda with aspartame may have a slightly higher chance of getting cancer, but it’s unclear if the sweetener itself is to blame or if it’s because these people tend to be heavier or eat worse.
Claim Context
Aspartame consumption is associated with an increased risk of cancer in large prospective cohort studies, particularly in French adults with long-term exposure, though confounding by obesity and metabolic status remains unresolved.
“A large prospective cohort study of 102,865 French adults... reported that aspartame and AceK consumption were associated with an elevated cancer risk. However, this association may be confounded by underlying characteristics of consumers—such as a higher prevalence of obesity, metabolic disorders, or specific dietary patterns—rather than indicating a direct carcinogenic effect of the sweeteners themselves.”
Evidence from Studies
No evidence studies found yet.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Whether aspartame intake consistently correlates with cancer incidence across populations after adjusting for BMI and dietary patterns.
A systematic review and meta-analysis of 20+ prospective cohort studies with validated dietary intake, BMI tracking, and cancer registry linkage in adults aged 30–75, stratifying by aspartame dose and adjusting for obesity, smoking, and processed food intake.
Whether aspartame causes DNA damage or tumor promotion in humans over time.
A double-blind RCT of 5,000 adults with prediabetes or obesity, randomized to 40 mg/kg/day aspartame or placebo for 10 years, with annual cancer screening and biomarkers (e.g., 8-OHdG, telomere length, inflammatory markers).
Whether long-term aspartame use predicts cancer incidence in real-world populations.
A prospective cohort of 50,000 adults with repeated 24-hour dietary recalls and plasma aspartame metabolite measurements over 20 years, tracking incident cancers by organ site (e.g., breast, brain, liver).
Whether cancer patients had higher prior aspartame intake than matched controls.
A case-control study of 1,000 adults with newly diagnosed cancer (any type) and 1,000 matched controls, using validated food frequency questionnaires to estimate aspartame intake over the prior 10 years.
A regulatory risk assessment for IARC or WHO.
A monograph by the International Agency for Research on Cancer (IARC) evaluating all human, animal, and mechanistic data to classify aspartame as carcinogenic, probably carcinogenic, or not classifiable.